Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology

Experimental Neurology

Volumn 140, Issue 1, 1996, Pages 1-13

  Galpern, Wendy R ^a,c   Burns, Lindsay H ^a   Deacon, Terrence W ^a,d   Dinsmore, Jonathan ^e   Isacson, Ole ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY   (United States)

^e GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA PROBE; DOPAMINERGIC TRANSMISSION; GLIA CELL; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESENCEPHALON; MORPHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SWINE; TISSUE TRANSPLANTATION; XENOTRANSPLANTATION;

EID: 0030198586     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0109     Document Type: Article

References (61)

1. 1. ABERCROMBIE, A. 1946. Estimation of nuclear population from microtome sections. Anat. Rec. 94: 239-247.
2. 2. BIERER, B. E., G. HOLLÄNDER, D. FRUMAN, AND S. J. BURAKOFF. 1993. Cyclosporin A and FK506: Molecular mechanisms of immunosuppression and probes for transplantation biology. Curr. Opin. Neurobiol. 5: 763-773.
3. 3. BJÖRKLUND, A. 1992. Dopaminergic transplants in experimental parkinsonism: Cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2: 683-689.
4. 4. BJÖRKLUND, A. 1993. Better cells for brain repair. Nature 362: 414-415.
5. 5. BJÖRKLUND, A., S. B. DUNNETT, U. STENEVI, M. E. LEWIS, AND S. D. IVERSEN. 1980. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199: 307-333.
6. 6. BJÖRKLUND, A., U. STENEVI, S. B. DUNNETT, AND F. H. GAGE. 1982. Cross-species neural grafting in a rat model of Parkinson's disease. Nature 298: 652-654.
7. 7. BRUNDIN, P., G. BARBIN, O. ISACSON, M. MALLET, B. CHAMAK, A. PROCHIANTZ, F. H. GAGE, AND A. BJÖRKLUND. 1985. Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neurosci. Lett. 61: 79-84.
8. 8. BRUNDIN, P., G. BARBIN, R. E. STRECKER, O. ISACSON, A. PROCHIANTZ, AND A. BJÖRKLUND. 1988. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Dev. Brain Res. 39: 233-243.
9. 9. BRUNDIN, P., O. ISACSON, AND A. BJÖRKLUND. 1985. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331: 251-259.
10. 10. BRUNDIN, P., O. G. NILSSON, F. H. GAGE, AND A. BJÖRKLUND. 1985. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine containing neurons. Exp. Brain. Res. 60: 204-208.
11. 11. BRUNDIN, P., O. G. NILSSON, R. E. STRECKER, O. LINDVALL, B. ASTEDT, AND A. BJÖRKLUND. 1986. Behavioral effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65: 235-240.
12. 12. BRUNDIN, P., R. E. STRECKER, H. WIDNER, D. J. CLARKE, O. G. NILSSON, B. ÅSTEDT, O. LINDVALL, AND A. BJÖRKLUND. 1988. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behavior, and dopamine release. Exp. Brain Res. 70: 192-208.
13. 13. BRUNDIN, P., H. WIDNER, O. G. NILSSON, R. E. STRECKER, AND A. BJÖRKLUND. 1989. Intracerebral xenografts of dopamine neurons: The role of immunosuppression and the blood-brain barrier. Exp. Brain Res. 75: 195-207.
14. 14. CLARKE, D. J., P. BRUNDIN, R. E. STRECKER, O. G. NILSSON, A. BJÖRKLUND, AND O. LINDVALL. 1988. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73: 115-126.
15. 15. COLLIER, T. J., D. E. REDMOND, C. D. SLADEK, M. J. GALLAGHER, R. H. ROTH, AND J. R. SLADEK. 1987. Intracerebral grafting and culture of cryopreserved primate dopamine neurons. Brain Res. 436: 363-366.
16. 16. DANILOFF, J. K., W. C. LOW, R. P. BODONY, AND J. WELLS. 1985. Cross-species neural transplants of embryonic septal nuclei to the hippocampal formation of adult rats. Exp. Brain Res. 59: 73-82.
17. 17. DAWSON, T. M., J. P. STEINER, V. L. DAWSON, J. L. DINERMAN, G. R. UHL, AND S. H. SNYDER. 1993. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA 90: 9808-9812.
18. 18. DEACON, T. W., P. PAKZABAN, L. H. BURNS, J. DINSMORE, AND O. ISACSON. 1994. Cytoarchitectonic development, axon-glia relationships, and long distance axon growth of porcine striatal xenografts in rats. Exp. Neurol. 130: 151-167.
19. 19. DICKERSON, J. W. T., AND J. DOBBING. 1967. Prenatal and postnatal growth and development of the central nervous system of the pig. Proc. R. Soc. Brit. 166: 384-395.
20. 20. DUAN, W.-M., P. BRUNDIN, E. M. GRASBON-FRODL, AND H. WIDNER. 1996. Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats. Brain Res. 712: 199-212.
21. 21. DUNNETT, S. B., A. BJÖRKLUND, R. H. SCHMIDT, U. STENEVI, AND S. D. IVERSEN. 1983. Intracerebral grafting of neuronal cell suspensions. IV. Behavioral recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl. 522: 29-37.
22. 22. DURING, M. J., J. R. NAEGELE, K. L. O'MALLEY, AND A. I. GELLER. 1994. Long-term behavioral recovery in parkinsonian rats by HSV vector expressing tyrosine hydroxylase. Science 266: 1399-1402.
23. 23. FISHER, L. J., H. A. JINNAH, L. C. KALE, G. A. HIGGINS, AND F. H. GAGE. 1991. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce 1-dopa. Neuron 6: 371-380.
24. 24. FREED, C. R., R. E. BREEZE, N. L. ROSENBERG, S. A. SCHNECK, E. KRIEK, J.-X. QI, T. LONE, Y.-B. ZHANG, J. A. SNYDER, T. H. WELLS, L. O. RAMIG, L. THOMPSON, J. C. MAZZIOTTA, S. C. HUANG, S. T. GRAFTON, D. BROOKS, G. SAWLE, G. SCHROTER, AND A. A. ANSARI. 1992. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327: 1549-1555.
25. 25. FREEMAN, T. B., C. W. OLANOW, R. A. HAUSER, G. M. NAUERT, D. A. SMITH, C. V. BORLONGAN, P. R. SANBERG, D. A. HOLT, J. H. KORDOWER, F. J. G. VINGERHOETS, B. J. SNOW, D. CALNE, AND L. L. GAUGER. 1995. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Exp. Neurol. 38: 379-388.
26. 26. FREEMAN, T. B., J. C. WOJAK, L. BRANDEIS, J. P. MICHEL, J. PEARSON, AND E. S. FLAMM. 1988. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons. Prog. Brain Res. 78: 473-477.
27. 27. FRODL, E. M., W.-M. DUAN, H. SAUER, A. KUPSCH, AND P. BRUNDIN. 1994. Human embryonic dopamine neurons xenografted to the rat: Effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology, and function. Brain Res. 647: 286-298.
28. 28. GOETZ, C. G., G. T. STEBBINS, H. L. KLAWANS, W. C. KOLLER, R. G. GROSSMAN, R. A. E. BAKAY, R. D. PENN, AND U. P. F. N. T. REGISTRY. 1991. United parkinson foundation neurotransplantation registry on adrenal medullary transplants: Presurgical, and 1- and 2-year follow-up. Neurology 41: 1719-1722.
29. 29. HONEY, C. R., D. J. CLARKE, M. J. DALLMAN, AND H. M. CHARLTON. 1990. Human neural graft function in rats treated with anti-interleukin II antibody. Neuroreport 1: 247-249.
30. 30. HORELLOU, P., P. BRUNDIN, P. KALÉN, J. MALLET, AND A. BJÖRKLUND. 1990. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated striatum. Neuron 5: 393-402.
31. 31. HORELLOU, P., E. VIGNE, M.-N. CASTEL, P. BARNÉOUD, P. COLIN, M. PERRICAUDET, P. DELAÈRE, AND J. MALLET. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 6: 49-53.
32. 32. HUFFAKER, T. K., B. D. BOSS, A. S. MORGAN, N. T. NEFF, R. E. STRECKER, M. S. SPENCE, AND R. MIAO. 1989. Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease. Brain Res. 77: 329-336.
33. 33. ISACSON, O. 1995. Gene delivery in parkinson rat model. Science 269: 856-857.
34. 34. ISACSON, O., T. W. DEACON, P. PAKZABAN, W. R. GALPERN, J. DINSMORE, AND L. H. BURNS. 1995. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibers. Nature Med. 1: 1189-1194.
35. 35. KAPLITT, M. G., P. LEONE, R. J. SAMULSKI, X. XIAO, D. W. PFAFF, K. L. O'MALLEY, AND M. J. DURING. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8: 148-154.
36. 36. KORDOWER, J. H., T. B. FREEMAN, B. J. SNOW, F. J. G. VINGERHOETS, E. J. MUFSON, P. R. SANDBERG, R. A. HAUSER, D. A. SMITH, G. M. NAUERT, D. P. PERL, AND C. W. OLANOW. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332: 1118-1124.
37. 37. LINDVALL, O. 1995. Neural transplantation. Cell Transpl. 4: 393-400.
38. 38. LINDVALL, O., G. SAWLE, H. WIDNER, J. C. ROTHWELL, A. BJORKLUND, D. BROOKS, P. BRUNDIN, R. FRACKOWIAK, C. D. MARSDEN, P. ODIN, AND S. REHNCRONA. 1994. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35: 172-180.
39. 39. MARTINEZ-SERRANO, A., C. LUNDBERG, P. HORELLOU, W. FISCHER, C. BENTLAGE, K. CAMPBELL, R. D. G. MCKAY, J. MALLET, AND A. BJÖRKLUND. 1995. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J. Neurosci. 15: 5668-5680.
40. 40. NIKKHAH, G., J. EBERHARD, M. OLSSON, AND A. BJÖRKLUND. 1995. Preservation of fetal ventral mesencephalic cells by cool storage: In-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res. 687: 22-34.
41. 41. OETTINGER, H. F., A. RODRIQUE-WAY, J. J. BOUSQUET, AND A. S. B. EDGE. 1995. Porcine repeat element DNA: In situ detection of xenotransplanted cells. Cell Transpl. 4: 253-256.
42. 42. PAKZABAN, P., T. W. DEACON, L. H. BURNS, J. DINSMORE, AND O. ISACSON. 1995. A novel mode of immunoprotection of neural xenotransplants: Masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65: 983-996.
43. 43. PAKZABAN, P., AND O. ISACSON. 1994. Neural xenotransplantation: Reconstruction of neuronal circuitry across species barriers. Neuroscience 62: 989-1001.
44. 44. PATINO, P., E. H. KRIEK, C. J. HUTT, J. X. QI, AND C. R. FREED. 1992. Short term corticosteroid treatment impairs survival of fetal dopamine cells transplanted to a rat model of Parkinson's disease. Soc. Neurosci. Abstr. 18: 59.
45. 45. PEDERSEN, E. B., F. R. POULSON, J. ZIMMER, AND B. FINSEN. 1995. Prevention of mouse-rat xenograft rejection by a combination therapy of cyclosporin A, prednisolone and azathioprine. Exp. Brain Res. 106: 181-186.
46. 46. REDMOND, D. E., F. NAFTOLIN, T. J. COLLIER, C. LERANTH, R. J. ROBBINS, C. D. SLADEK, R. H. ROTH, AND J. R. SLADEK. 1988. Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys. Science 242: 768-771.
47. 47. SABATÉ, O., P. HORELLOU, E. VIGNE, P. COLIN, M. PERRICAUDET, M.-H. BUC-CARON, AND J. MALLET. 1995. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirus. Nature Genet. 9: 256-260.
48. 48. SACHER, G. A., AND E. F. STAFFELDT. 1974. Relation of gestation time to brain weight in placental mammals. Am. Natur. 108: 593-616.
49. 49. SAUER, H., AND P. BRUNDIN. 1991. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci. 2: 123-135.
50. 50. SAUER, H., E. M. FRODL, A. KUPSCH, G. TEN BRUGGENCATE, AND W. H. OERTEL. 1992. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp. Brain Res. 90: 54-62.
51. 51. SCHMIDT, R. H., A. BJÖRKLUND, U. STENEVI, S. B. DUNNETT, AND F. H. GAGE. 1983. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl. 522: 19-28.
52. 14C]2-deoxy-D-glucose autoradiography. J. Neurochem. 38: 737-748.
53. 53. SNOW, M. H. L., AND P. P. L. TAM. 1980. Timing in embryological development. Nature 286: 107.
54. 54. STRECKER, R. E., T. SHARP, P. BRUNDIN, T. ZETTERSTRÖM, U. UNGERSTEDT, AND A. BJÖRKLUND. 1987. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 22: 169-178.
55. 55. STRÖMBERG, I., M. BYGDEMAN, M. GOLDSTEIN, Å. SEIGER, AND L. OLSON. 1986. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: Evidence for functional recovery. Neurosci. Lett. 71: 271-276.
56. 56. UNGERSTEDT, U., AND G. W. ARBUTHNOTT. 1970. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485-493.
57. 57. WICTORIN, K., P. BRUNDIN, H. SAUER, O. LINDVALL, AND A. BJÖRKLUND. 1992. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J. Comp. Neurol. 323: 475-494.
58. 58. WIDNER, H., AND P. BRUNDIN. 1988. Immunological aspects of grafting in the mammalian central nervous system: A review and speculative synthesis. Brain Res. Rev. 13: 287-324.
59. 59. WIDNER, H., J. TETRUD, S. REHNCRONA, B. SNOW, P. BRUNDIN, B. GUSTAVII, A. BJORKLUND, O. LINDVALL, AND J. W. LANGSTON. 1992. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327: 1556-1563.
60. 60. WOLFF, J. A., L. J. FISHER, L. XU, H. A. JINNAH, P. J. LANGLAIS, P. M. IUVONE, K. L. O'MALLEY, M. B. ROSENBERG, S. SHIMOHAMA, T. FRIEDMANN, AND F. H. GAGE. 1989. Grafting of fibroblasts genetically modified to produce 1-dopa in a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 86: 9011-9014.
61. 61. ZHOU, H., AND R. D. LUND. 1993. Effects of the age of donor or host tissue on astrocyte migration from intracerebral xenografts of corpus callosum. Exp. Neurol. 122: 155-164.